Awada A - Search Results

1

[Retroperitoneal mixed malignant mullerian tumor : exceptional localisation and prognosis].

El Hachem G, Jungels C, Larsimont D, Awada A. El Hachem G, et al. Among authors: awada a. Rev Med Brux. 2018;39(3):146-149. doi: 10.30637/2018.17-072. Rev Med Brux. 2018. PMID: 29964388 Review. French.

2

[Multiple neoplasms: etiological problems and possibilities for prevention].

Awada A, Klastersky J. Awada A, et al. Rev Med Brux. 1992 Sep;13(7):239-42. Rev Med Brux. 1992. PMID: 1410966 Review. French.

3

Rates of topoisomerase II-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma.

Mano MS, Awada A, Di Leo A, Durbecq V, Paesmans M, Cardoso F, Larsimont D, Piccart M. Mano MS, et al. Among authors: awada a. Gynecol Oncol. 2004 Mar;92(3):887-95. doi: 10.1016/j.ygyno.2003.12.010. Gynecol Oncol. 2004. PMID: 14984957

4

[New trends in the management of common solid malignant tumors].

Klastersky J, Awada A. Klastersky J, et al. Among authors: awada a. Rev Med Brux. 2005 Sep-Oct;26(5):425-32. Rev Med Brux. 2005. PMID: 16318095 French.

5

[Kidney cancer: from biology to clinical medicine].

Lalami Y, Gil T, D'Hondt V, Piccart M, Awada A. Lalami Y, et al. Among authors: awada a. Rev Med Suisse. 2006 Mar 1;2(55):600-4, 606-8. Rev Med Suisse. 2006. PMID: 16562604 Review. French. No abstract available.

6

[HER2 and topoisomerase II alpha: useful clinical markers in breast cancer].

Larsimont D, Durbecq V, Awada A, Di Leo A. Larsimont D, et al. Among authors: awada a. Bull Cancer. 2008 Mar;95(3):344-51. doi: 10.1684/bdc.2008.0596. Bull Cancer. 2008. PMID: 18390415 Review. French.

7

Validation of the Institut Curie simplified prognostic score for breast cancer meningeal carcinomatosis.

Bidard FC, Lossignol D, Larsimont D, Piccart M, Awada A. Bidard FC, et al. Among authors: awada a. Ann Oncol. 2011 Feb;22(2):480-2. doi: 10.1093/annonc/mdq689. Epub 2010 Dec 20. Ann Oncol. 2011. PMID: 21177280 Free article. No abstract available.

8

El Hajj P, Journe F, Wiedig M, Laios I, Salès F, Galibert MD, Van Kempen LC, Spatz A, Badran B, Larsimont D, Awada A, Ghanem G. El Hajj P, et al. Among authors: awada a. Br J Cancer. 2013 Apr 30;108(8):1641-7. doi: 10.1038/bjc.2013.115. Epub 2013 Mar 21. Br J Cancer. 2013. PMID: 23519055 Free PMC article.

9

Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.

Rothé F, Laes JF, Lambrechts D, Smeets D, Vincent D, Maetens M, Fumagalli D, Michiels S, Drisis S, Moerman C, Detiffe JP, Larsimont D, Awada A, Piccart M, Sotiriou C, Ignatiadis M. Rothé F, et al. Among authors: awada a. Ann Oncol. 2014 Oct;25(10):1959-1965. doi: 10.1093/annonc/mdu288. Epub 2014 Jul 25. Ann Oncol. 2014. PMID: 25185240 Free article.

10

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.

El Hajj P, Gilot D, Migault M, Theunis A, van Kempen LC, Salés F, Fayyad-Kazan H, Badran B, Larsimont D, Awada A, Bachelot L, Galibert MD, Ghanem G, Journe F. El Hajj P, et al. Among authors: awada a. Br J Cancer. 2015 Jun 30;113(1):91-8. doi: 10.1038/bjc.2015.194. Epub 2015 Jun 11. Br J Cancer. 2015. PMID: 26068396 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters